Benzinga | Nov 9, 2021 05:49PM EST

Accelerate Diagnostics Q3 EPS $(0.15) Beats $(0.33) Estimate, Sales $3.12M Miss $3.91M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.33) by 54.55 percent. This is a 54.55 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $3.12 million which missed the analyst consensus estimate of $3.91 million by 20.15 percent. This is a 12.99 percent decrease over sales of $3.59 million the same period last year.